Cytochrome P-450 CYP3A Inhibitors

DBCAT000934Therapeutic category

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. A DrugBank category of 446 drugs. 354 of them are approved.

Also known as
CYP3A Inhibitors · Cytochrome P 450 CYP3A Inhibitors · Cytochrome P-450 CYP3A-Inhibitors · Cytochrome P450 3A Inhibitor · Cytochrome P450 3A Inhibitors

What you can answer from here — as of September 15, 2022

446DrugsEach linked to its full drug card
Sign in
975Drug targetsEvery drug–target pair in the class, with bond type
Sign in
144,730Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
58Routes of administrationHow the drugs in this class are given
Sign in
4SubcategoriesNarrower classes within this one
Sign in

Which targets do Cytochrome P-450 CYP3A Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account